Jaguar Health Enters Non-dilutive Binding Term Sheet for $6.0 Million Sale of Partial Rights to Possible Tropical Disease Priority Review Voucher
Press release content from Accesswire. The AP news staff was not involved in its creation. Jaguar Health Enters Non-dilutive Binding Term Sheet for $6.0 Million Sale of Partial Rights to Possible Tropical Disease Priority Review Voucher January 13, 2021 GMT This additional non-dilutive financing will support development program for lechlemer for the indication of the symptomatic relief of diarrhea and dehydration in cholera patients REMINDER: Jaguar-hosted investor webcast scheduled for Thursda...
Lisa Conte Peter Hodge Centers For Disease Jaguar Health Inc National Institute Of Allergy National Institutes Of Health
Source: apnews.com